Researchers linked the condition to warfarin use, diabetes, obesity, recurrent skin trauma, and derangements in mineral metabolism.
In-hospital mortality risk was more than double among patients whose hyperkalemia persisted than those whose potassium levels normalized.
Treatment linked to improved long-term survival, regardless of underlying kidney function.
Findings from a small study suggest that periodontal disease may be a relevant contributing factor.
Iranian study of hemodialysis patients with secondary hyperparathyroidism finds no significant correlation.
Intact parathyroid hormone levels fell significantly in all patients who underwent total Ptx with autotransplant and 91.6% of subtotal Ptx patients.
The non-surgical approach effectively lowered serum parathyroid hormone levels in the short term, but not to the same extent as surgery.
A higher proportion of cinacalcet than placebo recipients met the primary efficacy endpoint of PTH levels of 250 pg/mL or less (25.4% vs. 3.5%).
Trend is independent of intravenous iron use and exposure to erythropoiesis-stimulating agents.
Researchers argue that little evidence exists to support this approach to prevent hyperkalemia.
No new adverse events observed in patients with underlying cardiovascular risk factors who switched to continuous erythropoietin receptor activator.
Researchers suggest conservative care may be suitable option for some patients over 80.
Observed rates of all-cause and cardiovascular mortality and myocardial infarction were consistent with expected rates, study shows.
Researchers observe an 81% increase in dialysis patients achieving recommended phosphorus levels after switching to sucroferric oxyhydroxide.
Study also identifies clinical characteristics associated with testosterone deficiency in this population.
The condition is independently associated with a 60% increased risk of 5-year mortality in maintenance hemodialysis patients.
Trend started around the introduction of the Medicare prospective payment system for dialysis care.
African-American children are 64% more likely to die than white children.
Researchers observe significantly higher levels of albumin and hemoglobin and better calcium and phosphate metabolism.
The need for this approach varies by season, researchers from Qatar report.
Meta-analysis reveals especially poor scores in attention and memory on neuropsychological tests.
Study finds a 3-folder greater risk of early death within a year of hemodialysis initiation.
Small case series also confirmed that the diagnosis of calciphylaxis is rarely made in the nodular, non-ulcerative phase.
Patients with preserved residual kidney function experience a survival benefit.
Use of oral megestrol acetate (MA) is associate with significant adverse effects.
Dialysis providers and facilities should assess and improve infection control practices.
Factors include care practices of physicians, sources of momentum, patient-physician interactions.
In a phase 2 trial, etelcalcitide, a novel peptide agonist of the calcium-sensing receptor, significantly reduced parathyroid hormone levels.
Study shows benefit of initiating epoetin beta therapy at hemoglobin levels not less than 10 g/dL in non-dialysis CKD patients.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)